BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 2681758)

  • 1. Circulating immune complexes and rheumatoid arthritis: the induction of immune complex formation between rheumatoid factor and IgG by polyethylene glycol.
    Faaber P; van den Bersselaar LA; van de Putte L; van den Berg WB
    J Rheumatol; 1989 Oct; 16(10):1304-9. PubMed ID: 2681758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating immune complexes and rheumatoid arthritis.
    Faaber P; Rijke Schilder TP; Capel PJ; Koene RA
    J Rheumatol; 1985 Oct; 12(5):849-53. PubMed ID: 3878875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune complexes from rheumatoid arthritis synovial fluid induce FcgammaRIIa dependent and rheumatoid factor correlated production of tumour necrosis factor-alpha by peripheral blood mononuclear cells.
    Mathsson L; Lampa J; Mullazehi M; Rönnelid J
    Arthritis Res Ther; 2006; 8(3):R64. PubMed ID: 16569263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune complex formation between IgM rheumatoid factor and IgG generated by hyaluronic acid.
    Faaber P; van den Bersselaar LA; van de Putte LB; van den Berg WB
    Arthritis Rheum; 1989 Dec; 32(12):1521-7. PubMed ID: 2688658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The detection of circulating immune complexes containing immunoglobulin G.
    Valentijn RM; van Es LA; Westedt ML; Daha MR
    J Clin Lab Immunol; 1984 Jun; 14(2):73-9. PubMed ID: 6748049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The stimulation of IgM rheumatoid factor from human B lymphocytes by rheumatoid arthritis complement-activating immune complexes.
    Lorber M; Samuel D; Amlot P; Panayi GS
    Clin Exp Immunol; 1988 Feb; 71(2):275-80. PubMed ID: 3258207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune complexes in sera and synovial fluids of patients with rheumatoid arthritis. Radioimmunoassay with monocylonal rheumatoid factor.
    Luthra HS; McDuffie FC; Hunder GG; Samayoa EA
    J Clin Invest; 1975 Aug; 56(2):458-66. PubMed ID: 125289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitation and characterization of soluble immune complexes precipitated from sera by polyethylene glycol (PEG).
    Chia D; Barnett EV; Yamagata J; Knutson D; Restivo C; Furst D
    Clin Exp Immunol; 1979 Sep; 37(3):399-407. PubMed ID: 315842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunochemical analyses of components of immune complexes in the sera of patients with autoimmune diseases.
    Ferraccioli G; Karsh J; Osterland CK
    J Rheumatol; 1983 Dec; 10(6):881-8. PubMed ID: 6663592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating immune complexes in patients with rheumatoid arthritis and the effect of penicillamine in vitro.
    Crawhall JC
    Clin Invest Med; 1984; 7(1):53-8. PubMed ID: 6723125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative study of complement components in polyethylene glycol precipitated immune complexes from patients with ovarian cancer and patients with rheumatoid arthritis.
    Mooney NA; Hay FC; Poulton TA
    Clin Exp Immunol; 1983 Jun; 52(3):561-8. PubMed ID: 6603297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interference of rheumatoid factor activity by aspartame, a dipeptide methyl ester.
    Ramsland PA; Movafagh BF; Reichlin M; Edmundson AB
    J Mol Recognit; 1999; 12(4):249-57. PubMed ID: 10440996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced complement-mediated immune complex solubilizing capacity and the presence of incompletely solubilized immune complexes in SLE sera.
    Baatrup G; Petersen I; Jensenius JC; Svehag SE
    Clin Exp Immunol; 1983 Nov; 54(2):439-47. PubMed ID: 6652967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection and partial characterization of immune complexes in patients with rheumatoid arthritis plus Sjogren's syndrome and with Sjogren's syndrome alone.
    Yoshinoya S; McDuffy S; Alarcon-Segovia D; Pope RM
    Clin Exp Immunol; 1982 May; 48(2):339-47. PubMed ID: 6980743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interference of rheumatoid factor activity by aspartame, a dipeptide methyl ester.
    Ramsland PA; Movafagh BF; Reichlin M; Edmundson AB
    J Mol Recognit; 1999; 12(5):249-57. PubMed ID: 10777254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Circulating immune complexes and anti-IgG antibodies in rheumatoid arthritis].
    Duquesnoy B; Santoro F; Wattre P; Delcambre B
    Rev Rhum Mal Osteoartic; 1978 Jun; 45(6):417-21. PubMed ID: 308254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection and characterization of circulating immune complexes in rheumatoid arthritis.
    Wattre P; Santoro F; Bout D; Defrance D; Capron A
    Biomedicine; 1976 Sep; 25(7):249-51. PubMed ID: 990384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for a disease specific antigen in circulating immune complexes in ankylosing spondylitis.
    Bruneau C; Bonin H
    Clin Exp Immunol; 1983 Sep; 53(3):529-35. PubMed ID: 6616954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The specific detection of IgG, IgA and the complement components C3 and C4 in circulating immune complexes.
    Valentijn RM; van Es LA; Daha MR
    J Clin Lab Immunol; 1984 Jun; 14(2):81-6. PubMed ID: 6748050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential precipitation of the Clq subcomponent of the first complement component (C1) by polyethylene glycol from normal human serum and sera of patients with collagen diseases.
    Van Dijk H; Van Voorst J; Jankowski IG; Imhof JW; Kerckhaert JA
    Clin Exp Immunol; 1984 Aug; 57(2):495-501. PubMed ID: 6432386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.